From Wikipedia, the free encyclopedia
(Redirected from SLC25A32 deficiency)

Riboflavin-responsive exercise intolerance (SLC25A32 deficiency) is a rare disorder caused by mutations of the SLC25A32 gene that encodes the mitochondrial folate transporter. Patients suffer from exercise intolerance and may have disrupted motor function.

A positive correlation between SLC25A32 dysfunction and flavoenzyme deficiency has been observed suggesting that SLC25A32 is in fact a mitochondrial FAD transporter. In mice studies, besides β-oxidation and amino acid metabolism being impaired by mitochondrial FAD deficiency, Slc25a32 wipeout embryos experienced dysfunction of the glycine cleavage system– dihydrolipoamide dehydrogenase. This dihydrolipoamide dehydrogenase dysfunction disrupted folate-mediated one-carbon metabolism, leading a deficiency of 5-methyltetrahydrofolate. [1]

Treatment with riboflavin, 5-formyltetrahydrofolate (Folinic acid) and/or L-5-methyltetrahydrofolate (5-MTHF) may lead to a drastic improvement of symptoms. Pyridoxal - 5 - Phosphate (P5P), a cofactor for the enzyme Serine hydroxymethyltransferase, may also assist with the conversion of tetrahydrofolate (THF) to 5,10-Methylenetetrahydrofolate (5,10-CH2-THF) a direct precursor to L-5-methyltetrahydrofolate (5-MTHF).

Symptoms

Patients suffer from exercise intolerance and may also have neuromuscular symptoms such as ataxia, dysarthia and muscle weakness. Staining of skeletal muscle samples with hematoxylin and eosin may reveal the ragged red fibers sign indicating disrupted mitochondrial function. In some patients, hypoketotic hypoglycemia was described. [2]

History

Riboflavin - responsive exercise intolerance was first described in 2016 by Schiff et al. [3]

See also

References

  1. ^ Peng, Min-Zhi; Shao, Yong-Xian; Li, Xiu-Zhen; Zhang, Kang-Di; Cai, Yan-Na; Lin, Yun-Ting; Jiang, Min-Yan; Liu, Zong-Cai; Su, Xue-Ying; Zhang, Wen; Jiang, Xiao-Ling; Liu, Li (2022-06-21). "Mitochondrial FAD shortage in SLC25A32 deficiency affects folate-mediated one-carbon metabolism". Cellular and Molecular Life Sciences. 79 (7): 375. doi: 10.1007/s00018-022-04404-0. ISSN  1420-9071. PMC  11072207. PMID  35727412. S2CID  249885944.
  2. ^ Al Shamsi B, Al Murshedi F, Al Habsi A, Al-Thihli K (November 2021). "Hypoketotic hypoglycemia without neuromuscular complications in patients with SLC25A32 deficiency". European Journal of Human Genetics. 30 (8): 976–979. doi: 10.1038/s41431-021-00995-7. PMC  9349259. PMID  34764427.
  3. ^ Schiff M, Veauville-Merllié A, Su CH, Tzagoloff A, Rak M, Ogier de Baulny H, Boutron A, Smedts-Walters H, Romero NB, Rigal O, Rustin P, Vianey-Saban C, Acquaviva-Bourdain C (February 2016). "SLC25A32 Mutations and Riboflavin-Responsive Exercise Intolerance". The New England Journal of Medicine. 374 (8): 795–7. doi: 10.1056/NEJMc1513610. PMC  4867164. PMID  26933868.
From Wikipedia, the free encyclopedia
(Redirected from SLC25A32 deficiency)

Riboflavin-responsive exercise intolerance (SLC25A32 deficiency) is a rare disorder caused by mutations of the SLC25A32 gene that encodes the mitochondrial folate transporter. Patients suffer from exercise intolerance and may have disrupted motor function.

A positive correlation between SLC25A32 dysfunction and flavoenzyme deficiency has been observed suggesting that SLC25A32 is in fact a mitochondrial FAD transporter. In mice studies, besides β-oxidation and amino acid metabolism being impaired by mitochondrial FAD deficiency, Slc25a32 wipeout embryos experienced dysfunction of the glycine cleavage system– dihydrolipoamide dehydrogenase. This dihydrolipoamide dehydrogenase dysfunction disrupted folate-mediated one-carbon metabolism, leading a deficiency of 5-methyltetrahydrofolate. [1]

Treatment with riboflavin, 5-formyltetrahydrofolate (Folinic acid) and/or L-5-methyltetrahydrofolate (5-MTHF) may lead to a drastic improvement of symptoms. Pyridoxal - 5 - Phosphate (P5P), a cofactor for the enzyme Serine hydroxymethyltransferase, may also assist with the conversion of tetrahydrofolate (THF) to 5,10-Methylenetetrahydrofolate (5,10-CH2-THF) a direct precursor to L-5-methyltetrahydrofolate (5-MTHF).

Symptoms

Patients suffer from exercise intolerance and may also have neuromuscular symptoms such as ataxia, dysarthia and muscle weakness. Staining of skeletal muscle samples with hematoxylin and eosin may reveal the ragged red fibers sign indicating disrupted mitochondrial function. In some patients, hypoketotic hypoglycemia was described. [2]

History

Riboflavin - responsive exercise intolerance was first described in 2016 by Schiff et al. [3]

See also

References

  1. ^ Peng, Min-Zhi; Shao, Yong-Xian; Li, Xiu-Zhen; Zhang, Kang-Di; Cai, Yan-Na; Lin, Yun-Ting; Jiang, Min-Yan; Liu, Zong-Cai; Su, Xue-Ying; Zhang, Wen; Jiang, Xiao-Ling; Liu, Li (2022-06-21). "Mitochondrial FAD shortage in SLC25A32 deficiency affects folate-mediated one-carbon metabolism". Cellular and Molecular Life Sciences. 79 (7): 375. doi: 10.1007/s00018-022-04404-0. ISSN  1420-9071. PMC  11072207. PMID  35727412. S2CID  249885944.
  2. ^ Al Shamsi B, Al Murshedi F, Al Habsi A, Al-Thihli K (November 2021). "Hypoketotic hypoglycemia without neuromuscular complications in patients with SLC25A32 deficiency". European Journal of Human Genetics. 30 (8): 976–979. doi: 10.1038/s41431-021-00995-7. PMC  9349259. PMID  34764427.
  3. ^ Schiff M, Veauville-Merllié A, Su CH, Tzagoloff A, Rak M, Ogier de Baulny H, Boutron A, Smedts-Walters H, Romero NB, Rigal O, Rustin P, Vianey-Saban C, Acquaviva-Bourdain C (February 2016). "SLC25A32 Mutations and Riboflavin-Responsive Exercise Intolerance". The New England Journal of Medicine. 374 (8): 795–7. doi: 10.1056/NEJMc1513610. PMC  4867164. PMID  26933868.

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook